Role of JNK signaling in oral cancer: A mini review
Open accessThe DOI matches its Crossref record; 106 of the 106 references it cites were found in a registry or an index.
Abstract
JNKs (c-Jun N-terminal kinases) belong to mitogen-activated protein kinases' family and become activated by several growth factors, stress, radiation, and other extracellular signals. In turn, JNK activation results in phosphorylation of downstream molecules involved in many normal cellular processes. Nevertheless, recent data have linked JNK signaling with several pathological conditions, including neurodegenerative diseases, inflammation, and cancer. The role of JNK in cancer remains controversial. Initially, JNK was thought to play a rather oncosuppressive role by mediating apoptosis in response to stress stimuli, inflammatory, or oncogenic signals. However, a number of studies have implicated JNK in malignant transformation and tumor growth. The contradictory functions of JNK in cancer may be due to the diversity of JNK upstream and downstream signaling and are under intensive investigation. This review summarizes current literature focusing on the significance of JNK pathway in cancer development and progression, particularly addressing its role in oral cancer. Understanding the complexity of JNK signaling has the potential to elucidate important molecular aspects of oral cancer, possibly leading to development of novel and individualized therapeutic strategies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In general, the activation of ERK by growth factors, hormones and proinflammatory stimuli promotes cell proliferation, whereas the activation of p38 and JNK by cellular and environmental stresses promotes multiple cellular processes such as proliferation, apoptosis, immunological effects, insulin signaling and neuronal activity [ 5 ].”
From MAPK Pathways in Ocular Pathophysiology: Potential Therapeutic Drugs and Challenges (2023) · cites this paper as [5]
In the citing paper
“In general, the activation of ERK by growth factors, hormones and proinflammatory stimuli promotes cell proliferation, whereas the activation of p38 and JNK by cellular and environmental stresses promotes multiple cellular processes such as proliferation, apoptosis, immunological effects, insulin signaling and neuronal activity [ 5 ].”
From MAPK Pathways in Ocular Pathophysiology: Potential Therapeutic Drugs and Challenges (2023) · cites this paper as [5]
Citations
Cites
2 retracted
Lee, Y.-M., Auh, Q., Lee, D., Kim, J.-Y., Jung, H.-J., Lee, S., & Kim, E.-C. (2013) · BioMed Research International · doi:10.1155/2013/210604 · Cited by 33
RetractedFeng, C., He, K., Zhang, C., Su, S., Li, B., Li, Y., Duan, C.-Y., Chen, S., Chen, R., Liu, Y., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090388 · Cited by 19
RetractedSignal transduction by the JNK group of MAP kinases
Davis, R. J. (2000) · Cell · doi:10.1016/s0092-8674(00)00116-1 · Cited by 4,237
Kyriakis, J. M., & Avruch, J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.807 · Cited by 3,382
A central role for JNK in obesity and insulin resistance
Hirosumi, J., Tuncman, G., Chang, L., Görgün, C. Z., Uysal, K. T., Maeda, K., Karin, M., & Hotamisligil, G. S. (2002) · Nature · doi:10.1038/nature01137 · Cited by 3,359
MAP kinase signalling pathways in cancer
Dhillon, A. S., Hagan, S., Rath, O., & Kolch, W. (2007) · Oncogene · doi:10.1038/sj.onc.1210421 · Cited by 2,995
Signal integration by JNK and p38 MAPK pathways in cancer development
Wagner, E. F., & Nebreda, Á. R. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2694 · Cited by 2,586
Pathological roles of MAPK signaling pathways in human diseases
Kim, E. K., & Choi, E.-J. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.12.009 · Cited by 2,472
MAP Kinases in the Immune Response
Dong, C., Davis, R. J., & Flavell, R. A. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.091301.131133 · Cited by 1,662
Yamamoto, K., Ichijo, H., & Korsmeyer, S. J. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.12.8469 · Cited by 1,003
Research works printed but not linked: 8
- Waetzig V, 2005, Trends Pharmacol Sci, 26, 455
- Yang YM, 2003, Clin Cancer Res, 9, 391
- She QB, 2002, Cancer Res, 62, 1343
- Noutomi T, 2009, Oncol Rep, 22, 1169
- Lee YM, 2013, Biomed Res Int, 2013, 210604
- Hsu S, 2003, Anticancer Res, 23, 1533
- Ghose A, 2001, Cancer Res, 61, 7479
- Peng CY, 2012, Evid Based Complement Alternat Med, 2012, 732578
Cited by
JNK-signaling: A multiplexing hub in programmed cell death
Dhanasekaran, D. N., & Reddy, E. P. (2017) · Genes & Cancer · doi:10.18632/genesandcancer.155 · Cited by 358
“Analyses of JNK-regulated pathways have shown that they play a crucial role in both cell proliferation and cell death [17-20].”
BackgroundJNK signaling in cancer cell survival
Wu, Q., Wu, W., Fu, B., Shi, L., Wang, X., & Kuca, K. (2019) · Medicinal Research Reviews · doi:10.1002/med.21574 · Cited by 322
“The c‐Jun N‐terminal kinase (JNK) pathway is one of three well‐characterized MAPK pathways involved in the regulation of cellular activities.(2) Recent data link JNK signaling to a range of pathological conditions including neurodegenerative diseases, inflammation, and cancer progression.”
BackgroundThe role of CDC25C in cell cycle regulation and clinical cancer therapy: a systematic review
Liu, K., Zheng, M., Lu, R., Du, J., Zhao, Q., Li, Z., Li, Y., & Zhang, S. (2020) · Cancer Cell International · doi:10.1186/s12935-020-01304-w · Cited by 287
E3 ligases and deubiquitinating enzymes regulating the MAPK signaling pathway in cancers
Park, H.-B., & Baek, K.-H. (2022) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2022.188736 · Cited by 177
Selective inhibitors for JNK signalling: a potential targeted therapy in cancer
Wu, Q., Wu, W., Jacevic, V., Franca, T. C. C., Wang, X., & Kuca, K. (2020) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2020.1720013 · Cited by 171
Metadata
- Authors
- Gkouveris, I., & Nikitakis, N. G.
- Affiliations
- University of California, Los Angeles (US)
- National and Kapodistrian University of Athens (GR)
- Corresponding author
- Gkouveris, Ioannis
- Venue
- Tumor Biology
- Publisher
- SAGE Publications
- Published
- 2017-06
- Volume
- 39
- Issue
- 6
- Pages
- 101042831771165
- ISSN
- 1010-4283 (ISSN-L)
- 1423-0380
- OpenAlex
- W2723510903
- Cited by
- 87
- References
- 106
- Citations by year
- 2026: 3 · 2025: 10 · 2024: 11 · 2023: 11 · 2022: 14 · 2021: 12 · 2020: 10 · 2019: 10 · 2018: 5 · 2017: 1
- FWCI
- 0.67
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Tumor Biology (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
- Health Sciences › Medicine › Otorhinolaryngology › Head and Neck Cancer Studies
- Keywords
- JNK signaling, c-Jun N-terminal kinase, oral cancer, mitogen-activated protein kinase, apoptosis, malignant transformation, tumor growth, tumor progression, therapeutic target
- MeSH terms
- Enzyme Activation, Humans, Mouth Neoplasms, Phosphorylation, Signal Transduction, Apoptosis, MAP Kinase Signaling System, JNK Mitogen-Activated Protein Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Role of JNK signaling in oral cancer: A mini review. https://app.cochat.ai/papers/10.1177/1010428317711659
- The paper
- Gkouveris, I., & Nikitakis, N. G. (2017). Role of JNK signaling in oral cancer: A mini review. Tumor Biology. https://doi.org/10.1177/1010428317711659
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.